RESPRIDX Trademark

Trademark Overview

On Monday, October 16, 2017, a trademark application was filed for RESPRIDX with the United States Patent and Trademark Office. The USPTO has given the RESPRIDX trademark a serial number of 87647404. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, December 21, 2023. This trademark is owned by Interpace Diagnostics, LLC. The RESPRIDX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

medical diagnostic testing services to detect lung cancer
respridx

General Information

Serial Number87647404
Word MarkRESPRIDX
Filing DateMonday, October 16, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, December 21, 2023
Registration Number5504939
Registration DateTuesday, June 26, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2018

Trademark Statements

Goods and Servicesmedical diagnostic testing services to detect lung cancer

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 25, 2017
Primary Code044
First Use Anywhere DateMonday, January 29, 2018
First Use In Commerce DateMonday, January 29, 2018

Trademark Owner History

Party NameInterpace Diagnostics, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054
Party NameInterpace Diagnostics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054
Party NameInterpace Diagnostics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Thursday, December 21, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, December 21, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, December 21, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 8, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 8, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 8, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 8, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 8, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 26, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, June 26, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, February 6, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 26, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, May 22, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, May 21, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, April 30, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 10, 2018USE AMENDMENT FILED
Monday, April 30, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 10, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, April 10, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 4, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 3, 2018ASSIGNED TO EXAMINER
Wednesday, October 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 19, 2017NEW APPLICATION ENTERED

Related Keywords

respridx lung cancer detect services diagnostic testing medical